Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA)
D. Zou (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), O. Basoglu (Izmir, Turkey), J. Verbraecken (Antwerp, Belgium), S. Schiza (Heraklion, Greece), P. Sliwinski (Warsaw, Poland), P. Steiropoulos (Alexandroupolis, Greece), H. Hein (Reinbeck, Germany), J. Pépin (Grenoble, France), G. Parati (Milan, Italy), W. Mcnicholas (Dublin, Ireland), J. Hedner (Gothenburg, Sweden)
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Zou (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), O. Basoglu (Izmir, Turkey), J. Verbraecken (Antwerp, Belgium), S. Schiza (Heraklion, Greece), P. Sliwinski (Warsaw, Poland), P. Steiropoulos (Alexandroupolis, Greece), H. Hein (Reinbeck, Germany), J. Pépin (Grenoble, France), G. Parati (Milan, Italy), W. Mcnicholas (Dublin, Ireland), J. Hedner (Gothenburg, Sweden). Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA). 4933
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Independent associations between arterial bicarbonate, apnea severity and hypertension in a sleep apnea cohort Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Mild obstructive sleep apnoea (OSA) and arterial hypertension in the EuropeanSleep Apnoea Database (ESADA) cohort study. Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA) Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
Relationship of arterial hypertension and obstructive sleep apnea syndrome Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Adherence to continuous positive airway pressure therapy (CPAP) in patients with obstructive sleep apnea (OSA) in an Asian privately funded healthcare system Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Predictors of titrating pressure using A-CPAP in obstructive sleep apnea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015
Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Weight changes in patients with obstructive sleep apnoea syndrome (OSAS) before and after CPAP Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly Year: 2014
Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Daytime sleepiness and cardiovascular complications in moderate to severe obstructive sleep apnoea (OSA) patients Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013
Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002
Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Resistant hypertension and obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013